[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.122.162. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News and Perspectives
November 21, 2007

FDA Bans Sale of Unapproved Cough Suppressants Containing Hydrocodone

JAMA. 2007;298(19):2251-2252. doi:10.1001/jama.298.19.2251

Physicians may be unknowingly prescribing cough suppressants that have not been approved by the US Food and Drug Administration (FDA), some of which may be unsafe for young children.

To address this situation, the agency is taking measures to stop the marketing of unapproved medicines containing hydrocodone, a semisynthetic opioid that acts as an analgesic and as an antitussive (cough suppressant). The main focus of the FDA's action, which the agency announced on September 28, centers on antitussive hydrocodone products, of which only 7 of approximately 200 are approved.

First Page Preview View Large
First page PDF preview
First page PDF preview
×